Pell Bio-Med Technology Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	49,573	20,062	4,722	-	-	-
Market Cap Growth	499.74%	324.81%	-	-	-	-
Enterprise Value	49,425	19,862	3,796	-	-	-
Last Close Price	766.00	342.50	81.01	-	-	-
PS Ratio	1577.56	638.42	240.56	-	-	-
PB Ratio	29.26	11.84	3.67	-	-	-
P/TBV Ratio	34.94	14.14	4.01	-	-	-
EV/Sales Ratio	-	632.08	193.39	-	-	-
Debt / Equity Ratio	0.14	0.14	0.28	0.15	0.25	0.60
Net Debt / Equity Ratio	-0.25	-0.25	-0.44	-0.79	-0.62	0.09
Net Debt / EBITDA Ratio	0.94	0.94	1.45	2.38	2.33	-0.11
Net Debt / FCF Ratio	0.83	0.83	1.09	4.75	3.02	-0.16
Asset Turnover	0.02	0.02	0.01	0.02	0.02	-
Inventory Turnover	5.60	5.60	6.43	10.59	6.45	-
Quick Ratio	2.15	2.15	2.93	12.47	12.49	2.86
Current Ratio	4.31	4.31	3.60	12.62	12.67	2.98
Return on Equity (ROE)	-30.38%	-30.38%	-32.02%	-40.20%	-44.50%	-
Return on Assets (ROA)	-15.15%	-15.15%	-16.34%	-20.88%	-20.52%	-
Return on Capital Employed (ROCE)	-25.90%	-25.90%	-29.00%	-30.90%	-23.90%	-56.00%
Earnings Yield	-0.86%	-2.11%	-8.25%	-	-	-
FCF Yield	-1.02%	-2.53%	-11.09%	-	-	-
Buyback Yield / Dilution	-2.77%	-2.77%	-23.33%	-17.94%	-17.87%	-

Source: S&P Capital IQ. Standard template. Financial Sources.